Advertisement

General Insurance Company Nepal Ltd (GIC)

Non-Life Insurance · Rs. 370.00 3.10 (+0.84%) as of Jul 13, 2022

Price — last 6 months

Full chart →
Open
367.00
High / Low
373.50 / 365.00
Prev. close
366.90
Volume
3,360
52-week high
809.00
52-week low
340.00
Market cap
Shares outstanding

MASTER score

Mechanical 0–100 technical ranking. Methodology →

Promoter holding
Public holding

Stock performance

1-week change
-8.64%
1-month change
-9.54%
3-month change
-34.51%
6-month change
-45.02%
YTD change
-36.09%
1-year change
-47.14%
1-month high
433.00
1-month low
340.00
From 52-week high
-54.26%
From 52-week low
+8.82%
180-day avg price
528.87
360-day avg price
579.69
Avg volume (1w)
4,769
Avg volume (1m)
2,885
Avg volume (6m)
5,489
Avg volume (12m)
7,910
Daily volatility (1m)
4.07%
Beta vs NEPSE (1y)

Valuation

EPS (annualized)
EPS (TTM)
P/E
P/B
Book value / share
ROE
ROA
Net profit margin
Graham number
Dividend yield
Dividend

P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →

Key indicators vs Non-Life Insurance

EPS (Rs.)
N/A
min avg max
P/E
N/A
min avg max
P/B
N/A
min avg max
Networth / Share (Rs.)
N/A
min avg max
ROE (%)
N/A
min avg max

Technical indicators

RSI (14)41.12Neutral
MACD-13.31Bullish
EMA 5375.34Bearish
EMA 20391.33Bearish
EMA 180527.53Bearish
SMA 50425.73Bearish
SMA 200554.34Bearish
Pivot levels (classic)
S3
357.00
S2
361.00
S1
365.50
PP
369.50
R1
374.00
R2
378.00
R3
382.50

Key financials — last 8 quarters

amounts in Rs · per-share in Rs

No filed statements found.

More Non-Life Insurance stocks

GIC — frequently asked questions

What is General Insurance Company Nepal Ltd's share price?

Rs. 370.00 as of Jul 13, 2022, the latest NEPSE trading session (+0.84% on the day).

What is GIC's 52-week range?

Rs. 340.00 to Rs. 809.00.

What dividend did GIC pay?

No dividend on record for the most recent fiscal year in our data.

Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.